| Literature DB >> 27178387 |
Nan Zhao1, Kang-Tao Tian1, Ke-Guang Cheng2, Tong Han1, Xu Hu1, Da-Hong Li3, Zhan-Lin Li1, Hui-Ming Hua4.
Abstract
The first series of nitric oxide donating derivatives of evodiamine were designed and prepared. NO releasing ability of all target derivatives was evaluated in BGC-823, Bel-7402 and L-02 cells. The cytotoxicity was evaluated against three human tumor cell lines (Bel-7402, A549 and BGC-823) and normal human liver cells L-02. The nitrate derivatives 11a and 11b only exhibited moderate activity and furoxan-based derivatives 13a-c, 14a and 14b showed promising activity. 13c showed good cytotoxic selectivity between tumor and normal liver cells and was further investigated for its apoptotic properties on human hepatocarcinoma Bel-7402 cells. The molecular mode of action revealed that 13c caused cell-cycle arrest at S phase and induced apoptosis in Bel-7402 cells through mitochondria-related caspase-dependent pathways.Entities:
Keywords: Antiproliferative activity; Apoptosis; Evodiamine; Nitric oxide
Mesh:
Substances:
Year: 2016 PMID: 27178387 DOI: 10.1016/j.bmc.2016.05.001
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641